Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25

Benzinga Newsdesk www.benzinga.com Positive 80.8%

Neg 0% Neu 0% Pos 80.8%

Citigroup analyst Brendan Digan maintains Sotera Health (NASDAQ:SHC) with a Buy and raises the price target from $23 to $25.